Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France

av Hiligsmann, M., Reginster, J.-Y.
I publikationen Osteoporos Int (2019)

Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice

av Donneau, A.-F., Reginster, J.-Y.
Publicerad 2013

Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: need for a concerted public health strategy.

av Reginster, J. Y., Gillet, P., Gosset, C.
Publicerad 2001

Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures

av Ethgen, O., Hiligsmann, M., Burlet, N., Reginster, J.-Y.
I publikationen Osteoporos Int (2015)

Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women

av Kanis, JA, Cooper, C, Rizzoli, R, Reginster, J-Y
I publikationen Calcif Tissue Int (2019)

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis

av Hiligsmann, M., Ben Sedrine, W., Bruyère, O., Reginster, J.-Y.
Publicerad 2013

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

av Kanis, J.A., Cooper, C., Rizzoli, R., Reginster, J.-Y.
I publikationen Osteoporos Int (2018)

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women

av Kanis, J.A., Cooper, C., Rizzoli, R., Reginster, J.-Y.
I publikationen Osteoporos Int (2020)

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

av Hiligsmann, M., Maggi, S., Veronese, N., Sartori, L., Reginster, J.-Y.
I publikationen Osteoporos Int (2021)

Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab

av Neuprez, A., Coste, S., Rompen, E., Crielaard, J. M., Reginster, J. Y.
Publicerad 2013

The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action

av Ethgen, O., Beaudart, C., Buckinx, F., Bruyère, O., Reginster, J. Y.
I publikationen Calcif Tissue Int (2016)

Pharmacological treatment of ambulatory schizophrenic patients in Belgium

av Hanssens, L, De Hert, M, Wampers, M, Reginster, J-Y, Peuskens, J
Publicerad 2006

Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France

av Hiligsmann, M., Burlet, N., Fardellone, P., Al-Daghri, N., Reginster, J.-Y.
I publikationen Osteoporos Int (2016)

Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women

av Chandran, M., Ganesan, G., Tan, K.B., Reginster, J.-Y., Hiligsmann, M.
I publikationen Osteoporos Int (2020)

Paget's disease of bone: diagnosis and management.

av Hosking, D., Meunier, P. J., Ringe, J. D., Reginster, J. Y., Gennari, C.
Publicerad 1996

Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database

av Breart, G., Cooper, C., Meyer, O., Speirs, C., Deltour, N., Reginster, J. Y.
Publicerad 2009

Paget's disease of bone treated with a five day course of oral tiludronate.

av Reginster, J Y, Lecart, M P, Deroisy, R, Ethgen, D, Zegels, B, Franchimont, P
Publicerad 1993

Bone health assessment in older people with or without muscle health impairment

av Locquet, M., Beaudart, C., Bruyère, O., Kanis, J. A., Delandsheere, L., Reginster, J.-Y.
I publikationen Osteoporos Int (2018)

Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis

av Reginster, J. -Y., Bianic, F., Campbell, R., Martin, M., Williams, S. A., Fitzpatrick, L. A.
I publikationen Osteoporos Int (2019)

Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review

av Cornelissen, D., de Kunder, S., Si, L., Reginster, J.-Y., Evers, S., Boonen, A., Hiligsmann, M.
I publikationen Osteoporos Int (2020)